Gurunathan Murugesan

2.2k total citations
21 papers, 954 citations indexed

About

Gurunathan Murugesan is a scholar working on Molecular Biology, Hematology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Gurunathan Murugesan has authored 21 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Hematology and 7 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Gurunathan Murugesan's work include Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Platelet Disorders and Treatments (4 papers). Gurunathan Murugesan is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (6 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Platelet Disorders and Treatments (4 papers). Gurunathan Murugesan collaborates with scholars based in United States and France. Gurunathan Murugesan's co-authors include Kandice Kottke‐Marchant, Paul L. Fox, Jaroslaw P. Maciejewski, Hadrian Szpurka, Eric D. Hsi, Samer Aboudola, Gaurisankar Sa, Yuri Ivashchenko, Michael Jaye and Roger Marchant and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Blood.

In The Last Decade

Gurunathan Murugesan

21 papers receiving 933 citations

Peers

Countries citing papers authored by Gurunathan Murugesan

Since Specialization

Citations

This map shows the geographic impact of Gurunathan Murugesan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gurunathan Murugesan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gurunathan Murugesan more than expected).

Fields of papers citing papers by Gurunathan Murugesan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gurunathan Murugesan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gurunathan Murugesan. The network helps show where Gurunathan Murugesan may publish in the future.

Co-authorship network of co-authors of Gurunathan Murugesan

This figure shows the co-authorship network connecting the top 25 collaborators of Gurunathan Murugesan. A scholar is included among the top collaborators of Gurunathan Murugesan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gurunathan Murugesan. Gurunathan Murugesan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The relation between ABO blood types and clinical and platelet function parameters in patients who underwent percutaneous coronary intervention 2018 ·Coronary Artery Disease ·Ayse Anil Timur, John Barnard, Gurunathan Murugesan, Sanjay Gandhi, Deepak L. Bhatt, Kandice Kottke‐Marchant	6
2	Thrombocytosis and STAT5 activation in chronic myelogenous leukaemia are not associated with JAK2 V617F or calreticulin mutations 2016 ·Journal of Clinical Pathology ·(unknown), Gurunathan Murugesan, Claudiu Cotta, Karl S. Theil	5
3	pSTAT3/pSTAT5 Signaling Patterns in Molecularly Defined Subsets of Myeloproliferative Neoplasms 2016 ·Applied immunohistochemistry & molecular morphology ·(unknown), (unknown), Gurunathan Murugesan, Juraj Bodo, Eric D. Hsi, James R. Cook	3
4	Multi-parameter assessment of platelet inhibition and its stability during aspirin and clopidogrel therapy 2014 ·Thrombosis Research ·Ayse Anil Timur, Gurunathan Murugesan, Li Zhang, (unknown), Deepak L. Bhatt, Kandice Kottke‐Marchant	6
5	P2RY1 and P2RY12 polymorphisms and on‐aspirin platelet reactivity in patients with coronary artery disease 2012 ·International Journal of Laboratory Hematology ·Ayse Anil Timur, Gurunathan Murugesan, Li Zhang, Phyu P. Aung, J. A. Barnard, Qing K. Wang, Pascale Gaussem, Roy L. Silverstein, Deepak L. Bhatt, Kandice Kottke‐Marchant	31
6	Pilot Candidate Gene Analysis of Patients ≥60 Years Old With Aortic Stenosis Involving a Tricuspid Aortic Valve 2012 ·The American Journal of Cardiology ·Stephen G. Ellis, (unknown), May M. Luke, Gurunathan Murugesan, Kandice Kottke‐Marchant, (unknown), Brian P. Griffin, E. Murat Tuzcu, (unknown)	12
7	Platelet CD36 surface expression levels affect functional responses to oxidized LDL and are associated with inheritance of specific genetic polymorphisms 2011 ·Blood ·Arunima Ghosh, Gurunathan Murugesan, Kan Chen, Li Zhang, Qing Wang, Maria Febbraio, (unknown), Kandice Marchant, John Barnard, Roy L. Silverstein	86
8	Management of patients with aspirin and clopidogrel impaired response 2009 ·Interventional Cardiology ·Jeremiah P. Depta, Deepak L. Bhatt, Kandice Kottke‐Marchant, Rishi Gupta, Gurunathan Murugesan, Anil Jain, A. Michael Lincoff, Stephen G. Ellis	1
9	Identification of the JAK2 V617F Mutation in Chronic Myeloproliferative Disorders Using FRET Probes and Melting Curve Analysis 2006 ·American Journal of Clinical Pathology ·Gurunathan Murugesan, Samer Aboudola, Hadrian Szpurka, (unknown), Jaroslaw P. Maciejewski, Raymond R. Tubbs, Eric D. Hsi	53
10	Refractory anemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T), another myeloproliferative condition characterized by JAK2 V617F mutation 2006 ·Blood ·Hadrian Szpurka, Ramón V. Tiu, Gurunathan Murugesan, Samer Aboudola, Eric D. Hsi, Karl S. Theil, Mikkael A. Sekeres, Jaroslaw P. Maciejewski	130
11	Creation of a large-scale genetic data bank for cardiovascular association studies 2005 ·American Heart Journal ·Ramtin Agah, Stephen G. Ellis, (unknown), Mark Henderson, (unknown), Gurunathan Murugesan, Raymond Tubbs, Kandice Marchant, Ilka Warshawsky, (unknown), Kathy Hughes, (unknown), Eric J. Topol	5
12	LightTyper™ platform for high-throughput clinical genotyping 2005 ·Expert Review of Molecular Diagnostics ·Gurunathan Murugesan, Kandice Kottke‐Marchant, Stephen G. Ellis, Ramtin Agah, Raymond Tubbs	6
13	Extracellular Matrix‐Like Surfactant Polymers Containing Arginine‐Glycine‐Aspartic Acid (RGD) Peptides 2004 ·Macromolecular Bioscience ·Eric H. Anderson, Mark Ruegsegger, Gurunathan Murugesan, Kandice Kottke‐Marchant, Roger Marchant	8
14	Human microvascular endothelial cell growth and migration on biomimetic surfactant polymers 2003 ·Biomaterials ·Sharon M. Sagnella, (unknown), Eric H. Anderson, Jacqueline E. King, Gurunathan Murugesan, Roger Marchant, Kandice Kottke‐Marchant	41
15	Membrane microviscosity regulates endothelial cell motility 2002 ·Nature Cell Biology ·(unknown), Amit Vasanji, Gurunathan Murugesan, Steven J. Eppell, Linda M. Graham, Paul L. Fox	73
16	Endothelial cell formation of focal adhesions on hydrophilic plasma polymers 2002 ·Biomaterials ·(unknown), Gurunathan Murugesan, Roger Marchant, Kandice Kottke‐Marchant	44
17	Integrin-Dependent Interaction of Human Vascular Endothelial Cells on Biomimetic Peptide Surfactant Polymers 2002 ·Cell Communication & Adhesion ·Gurunathan Murugesan, Mark Ruegsegger, (unknown), Roger Marchant, Kandice Kottke‐Marchant	18
18	Single Nucleotide Polymorphisms in Multiple Novel Thrombospondin Genes May Be Associated With Familial Premature Myocardial Infarction 2001 ·Circulation ·Eric J. Topol, Jeanette McCarthy, Stacey B. Gabriel, David J. Moliterno, William J. Rogers, L. Kristin Newby, (unknown), (unknown), (unknown), Christopher J. O’Donnell, Kandice Kottke‐Marchant, Gurunathan Murugesan, Edward F. Plow, Olga Stenina‐Adognravi, George Q. Daley	219
19	Endothelial cell expression of monocyte chemotactic protein-1, tissue factor, and thrombomodulin on hydrophilic plasma polymers 2000 ·Journal of Biomedical Materials Research ·Gurunathan Murugesan, M.R. Sandhya Rani, Richard M. Ransohoff, Roger Marchant, Kandice Kottke‐Marchant	19
20	Activation of Cytosolic Phospholipase A by Basic Fibroblast Growth Factor via a p42 Mitogen-activated Protein Kinase-dependent Phosphorylation Pathway in Endothelial Cells 1995 ·Journal of Biological Chemistry ·Gaurisankar Sa, Gurunathan Murugesan, Michael Jaye, Yuri Ivashchenko, Paul L. Fox	145

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact